Genetic and Environmental Risk Factors for Hemorrhagic Stroke
State University of New York at Buffalo · with National Institute of Neurological Disorders and Stroke (NINDS), University of Maryland, Baltimore · NCT00682695
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 5
- Study start
- January 1, 2025
- Record last updated
- July 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to find risk factors for hemorrhagic stroke.
Conditions: Stroke
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 or older
- Resident (6 months or longer) within the recruitment center
- Fulfillment of the criteria for spontaneous ICH
- No evidence of trauma, brain tumor/metastases or infectious processes as a cause of the hemorrhage
- Ability of the patient or legal representative to provide consent for an interview, blood pressure determinations and DNA sampling
Exclusion Criteria
- N/A
Recruiting US locations
Baptist Health Louisville
Louisville, KY 40207
Site contact: Karin Cryan · 5022595564 · karin.cryan@BHSI.COM
University of Maryland
Baltimore, MD 21201
Site contact: Tiffany Watson · 410-706-1902 · tiwatson@som.umaryland.edu
Massachusetts General Hospital
Boston, MA 02114
Site contact: Christina Kourkoulis · 617-726-5358 · CKOURKOULIS@PARTNERS.ORG
Duke University
Durham, NC 27710
Site contact: Andreea Podgoreanu · 919-681-4054 · andrea.podgoreanu@duke.edu
University of Cincinnati
Cincinnati, OH 45267
Site contact: Lee A Gilkerson, RN, BSN · 513-558-6140 · Lee.gilkerson@uc.edu
Study contacts (from the official record)
- Lee A Gilkerson, RN, BSN · 513-558-6140 · Lee.gilkerson@uc.edu
Similar studies in Kentucky
All neurology studies in Kentucky →- RecruitingPhase 1/Phase 2
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Sumitomo Pharma America, Inc.
- Location
- Lexington, KY + 2 other US sites
- Eligibility basics
- Ages 40–72
- RecruitingPhase 2
Strategy for Improving Stroke Treatment Response
Translational Sciences, Inc.
- Location
- Lexington, KY + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
H. Lundbeck A/S
- Location
- Lexington, KY + 8 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
argenx
- Location
- Nicholasville, KY + 15 other US sites
- Eligibility basics
- Ages 18+